← Back to Patent Explorer
US4337261A Expired / Lapsed US ⏱️ 0.0 years remaining

(1,2-Benzisoxazol)phenoxyacetic acids as diuretics

Assignee: Aventis Pharmaceuticals Inc
•
Filing: 1980-07-28
•
Granted: 1982-06-29
•
Expires: 2000-07-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel (1,2-benzisoxazol)phenoxyacetic acids and related compounds, methods for preparing same and methods of treatment by administering compositions containing such a compound are described. These compounds are useful as diuretics.

Inventors

  • 👤 Gregory M. Shutske
  • 👤 Linda L. Setescak
  • 👤 Richard C. Allen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 01:27
CPC Classifications
C; C07; C07D; C07D261/00; C07D261/20; A; A61; A61P; A61P7/00; A61P7/10; C07C; C07C45/00; C07C45/45; C07C45/46; C07C45/61; C07C45/67; C07C45/673; C07C49/00; C07C49/76; C07C49/84

Claims Analysis

Total Claims: 27
Claim 1
Independent Claim 47 words
A compound depicted by the formula ##STR10## in which R is Cl, CH 3 or Br; R 2 is Cl, Br or CH 3 ; R 1 is hydrogen or lower-alkyl; and X is hydrogen, halogen, loweralkyl, amino, acylamino or nitro; and a physiologically acceptable salt thereof.
Claim 2
Dependent Claim 47 words
A compound depicted by the formula ##STR10## in which R is Cl, CH 3 or Br; R 2 is Cl, Br or CH 3 ; R 1 is hydrogen or lower-alkyl; and X is hydrogen, halogen, loweralkyl, amino, acylamino or nitro; and a physiologically acceptable salt thereof.
Claim 3
Dependent Claim 16 words
The compound as defined in claim 1 wherein R and R 2 are CH 3 .
Claim 4
Dependent Claim 14 words
The compound as defined in claim 1 wherein R and R 2 are chlorine.
Claim 5
Dependent Claim 12 words
The compound as defined in claim 1 wherein R 1 is hydrogen.
Claim 6
Dependent Claim 11 words
The compound as defined in claim 1 which is ethyl 4-(1,2-benzisoxazol-3-yl)-2,3-dimethylphenoxyacetate.
Claim 7
Dependent Claim 15 words
The compound as defined in claim 1 which is 4-(1,2-benzisoxazol-3-yl)-2,3-dimethylphenoxyacetic acid or a salt thereof.
Claim 8
Dependent Claim 11 words
The compound as defined in claim 1 which is ethyl 4-(1,2-benzisoxazole-3-yl)-2,3-dichlorophenoxyacetate.
Claim 9
Dependent Claim 15 words
The compound as defined in claim 1 which is 4-(1,2-benzisoxazol-3-yl)-2,3-dichlorophenoxyacetic acid or a salt thereof.
Claim 10
Independent Claim 66 words
A method of producing diuresis which comprises administering to a patient in need of diuresis a diuretically effective amount of a compound depicted by the formula ##STR11## in which R is CI, CH 3 or Br; R 2 is Cl, CH 3 or Br; R 1 is hydrogen or lower-alkyl; and X is hydrogen, halogen, loweralkyl, amino, acylamino or nitro; and a physiologically acceptable salt thereof.
Claim 11
Independent Claim 66 words
A method of producing diuresis which comprises administering to a patient in need of diuresis a diuretically effective amount of a compound depicted by the formula ##STR11## in which R is CI, CH 3 or Br; R 2 is Cl, CH 3 or Br; R 1 is hydrogen or lower-alkyl; and X is hydrogen, halogen, loweralkyl, amino, acylamino or nitro; and a physiologically acceptable salt thereof.
Claim 12
Dependent Claim 20 words
The method as defined in claim 9 where said compound has R and R 2 which are CH 3 .
Claim 13
Dependent Claim 18 words
The method as defined in claim 9 where said compound has R and R 2 which are chlorine.
Claim 14
Dependent Claim 16 words
The method as defined in claim 9 where said compound has R 1 which is hydrogen.
Claim 15
Dependent Claim 13 words
The method as defined in claim 9 where said compound is ethyl 4-(1,2-benzisoxazol-3-yl)-2,3-dimethylphenoxyacetate.
Claim 16
Dependent Claim 17 words
The method as defined in claim 9 where said compound is 4-(1,2-benzisoxazol-2-yl)-2,3-dimethylphenoxyacetic acid or a salt thereof.
Claim 17
Dependent Claim 13 words
The method as defined in claim 9 where said compound is ethyl 4-(1,2-benzisoxazol-3-yl)-2,3-dichlorophenoxyacetate.
Claim 18
Dependent Claim 17 words
The method as defined in claim 9 where said compound is 4-(1,2-benzisoxazol-3-yl)-2,3-dichlorophenoxyacetic acid or a salt thereof.
Claim 19
Dependent Claim 56 words
A pharmaceutical composition comprising a pharmaceutically effective amount of a compound depicted by the formula ##STR12## in which R is Cl, Br or CH 3 ; R 2 is Cl, CH 3 or Br; R 1 is hydrogen or loweralkyl; and X is hydrogen, halogen, loweralkyl, amino, acylamino or nitro; and a physiologically acceptable salt thereof.
Claim 20
Dependent Claim 56 words
A pharmaceutical composition comprising a pharmaceutically effective amount of a compound depicted by the formula ##STR12## in which R is Cl, Br or CH 3 ; R 2 is Cl, CH 3 or Br; R 1 is hydrogen or loweralkyl; and X is hydrogen, halogen, loweralkyl, amino, acylamino or nitro; and a physiologically acceptable salt thereof.
Claim 21
Dependent Claim 20 words
The pharmaceutical composition defined in claim 17 wherein the R and R 2 of said compound are CH 3 .
Claim 22
Dependent Claim 18 words
The pharmaceutical composition defined in claim 17 wherein the R and R 2 of said compound are chlorine.
Claim 23
Dependent Claim 16 words
The pharmaceutical composition defined in claim 17 wherein the R 1 of said compound is hydrogen.
Claim 24
Dependent Claim 11 words
The pharmaceutical composition defined in claim 17 which comprises ethyl 4-(1,2-benzisoxazol-3-yl)-2,3-dimethylphenoxyacetate.
Claim 25
Dependent Claim 15 words
The pharmaceutical composition defined in claim 17 which comprises 4-(1,2-benzisoxazol-3-yl)-2,3-dimethylphenoxyacetic acid or a salt thereof.
Claim 26
Dependent Claim 11 words
The pharmaceutical composition defined in claim 17 which comprises ethyl 4-(1,2-benzisoxazol-3-yl)-2,3-dichlorophenoxyacetate.
Claim 27
Dependent Claim 15 words
The pharmaceutical composition defined in claim 17 which comprises 4-(1,2-benzisoxazol-3-yl)-2,3-dichlorophenoxyacetic acid or a salt thereof.

References Cited (Backward Citations)

BE744880A Cited
JPS487633U Cited
US3951999A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-06-28 1985-12-28 1986-06-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-06-28 1989-12-28 1990-06-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-06-28 1993-12-28 1994-06-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag